AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 26-50/55

Authors: KARKOSZKA H KALITA B KOKOT F WIECEK A SLIMOK M SIKORA A SZCZEPANSKI Z
Citation: H. Karkoszka et al., INFLUENCE OF GLUTEN-FREE DIET (GFD) ON BONE-MINERAL DENSITY (BMD) IN CHILDREN WITH CELIAC-DISEASE (CD), Gut, 41, 1997, pp. 216-217

Authors: WIECEK A KOLONKO A KOKOT F
Citation: A. Wiecek et al., ADENOSINE ANTAGONIST DOES PREVENT FUNCTIONAL AND HORMONAL ABNORMALITIES INDUCED BY RADIOGRAPHIC CONTRAST AGENTS (RCA), Journal of the American Society of Nephrology, 7(9), 1996, pp. 670-670

Authors: KOKOT F
Citation: F. Kokot, ETHICAL ISSUES IN NEPHROLOGY, Nephrology, dialysis, transplantation, 11(6), 1996, pp. 960-960

Authors: HEIDLAND A KOKOT F KOPPLE JD
Citation: A. Heidland et al., MASSRY,SHAUL,G., LOS-ANGELES, USA, Nephrology, dialysis, transplantation, 11(5), 1996, pp. 901-901

Authors: KOKOT F
Citation: F. Kokot, PROFESSOR VALEK,ALBERT, Nephrology, dialysis, transplantation, 11(4), 1996, pp. 729-729

Authors: WYSTRYCHOWSKI A NOWICKI M KOKOT F
Citation: A. Wystrychowski et al., HYPONATREMIC RENAL PSEUDOFAILURE - DONT FORGET THE POSSIBILITY OF UROPERITONEUM, Nephrology, dialysis, transplantation, 11(12), 1996, pp. 2491-2492

Authors: KOKOT F STEIN G MOLZAHN M HEIDLAND A
Citation: F. Kokot et al., THE 2ND POLISH-GERMAN SYMPOSIUM IN NEPHROLOGY AND HYPERTENSION - PREFACE, Clinical nephrology, 46(4), 1996, pp. 245-245

Authors: KOKOT F
Citation: F. Kokot, BIOCHEMICAL MONITORING OF DIABETIC-PATIENTS, Clinical nephrology, 46(4), 1996, pp. 266-268

Authors: KOKOT F
Citation: F. Kokot, ABNORMALITIES OF POTASSIUM METABOLISM IN CHRONIC UREMIA, Clinical nephrology, 46(4), 1996, pp. 276-277

Authors: KOKOT F
Citation: F. Kokot, ERYTHROPOIETIN-1994 - SELECTED ASPECTS OF CLINICAL RELEVANCE, Nieren- und Hochdruckkrankheiten, 25(10), 1996, pp. 508-512

Authors: WIECEK A KOKOT F
Citation: A. Wiecek et F. Kokot, DOES INDUSTRIAL-ENVIRONMENT INFLUENCE THE PREVALENCE OF ARTERIAL-HYPERTENSION, PLASMA-CHOLESTEROL, URIC-ACID CONCENTRATION, AND ACTIVITY OFTHE RENIN-ALDOSTERONE SYSTEM, Nieren- und Hochdruckkrankheiten, 25(10), 1996, pp. 519-522

Authors: VALDERRABANO F MADIAS NE SCHENA FP CARRERA F SILVERBERG D KOKOT F ZUCCHELLI P CANNATA J ESCHBACH JW MALLICK NP SELVAGGI G TEPLAN V EFSTRATOPOULOS AD CHANG JM VISWESWARAN K HURWICH B PAPADIMITRIOU M LASKER N MATHEW T
Citation: F. Valderrabano et al., ERYTHROPOIETIN IN CHRONIC-RENAL-FAILURE, Kidney international, 50(4), 1996, pp. 1373-1391

Authors: KOKOT F WIECEK A GRZESZCZAK W LAO M KUSMIERSKI S CIERPKA L GRADOWSKA L JAGIELLO R
Citation: F. Kokot et al., SERUM ERYTHROPOIETIN AND PARATHYROID-HORMONE CONCENTRATIONS IN KIDNEY-TRANSPLANT PATIENTS DURING ACUTE GRAFT-REJECTION, Transplantation proceedings, 28(6), 1996, pp. 3477-3479

Authors: FRANEK E KOKOT F GRZESZCZAK W GAJOS L
Citation: E. Franek et al., IS ANALGESIC NEPHROPATHY A PROBLEM IN THE SOUTH-WEST REGION OF POLAND, Nephron, 72(2), 1996, pp. 353-353

Authors: IRZYNIEC TJ WNUK RS KOKOT F
Citation: Tj. Irzyniec et al., RESPONSIVENESS OF PTH SECRETION TO A PHOSPHATE (P) LOAD IN PATIENTS WITH ESSENTIAL-HYPERTENSION (EH), Journal of the American Society of Nephrology, 6(3), 1995, pp. 623-623

Authors: KOKOT F WIECEK A SCHMIDTGAYK H MARCINKOWSKI W GILGE U HEIDLAND A RUDKA R TREMBECKI J
Citation: F. Kokot et al., FUNCTION OF ENDOCRINE ORGANS IN HEMODIALYZED PATIENTS OF LONG-TERM ERYTHROPOIETIN THERAPY, Artificial organs, 19(5), 1995, pp. 428-435

Authors: KOKOT F WIECEK A HEIDLAND A SCHMIDTGAYK H KUCZERA M KIERSZTEJN M
Citation: F. Kokot et al., ENDOCRINE FUNCTION OF THE ISCHEMIC KIDNEY, Kidney international, 47(2), 1995, pp. 666-666

Authors: KOKOT F WIECEK A
Citation: F. Kokot et A. Wiecek, ARTERIAL-HYPERTENSION IN UREMIC PATIENTS TREATED WITH ERYTHROPOIETIN, Nephron, 71(2), 1995, pp. 127-132

Authors: WIECEK A KOKOT F MARCINKOWSKI W
Citation: A. Wiecek et al., LONG-TERM PERSISTENCE OF IMPROVEMENT OF RENAL ANEMIA IN SPITE OF DISCONTINUED ERYTHROPOIETIN TREATMENT, Nephron, 69(4), 1995, pp. 489-490

Authors: KOKOT F KLIMEK D WIECEK A DULAWA J
Citation: F. Kokot et al., ATRIAL-NATRIURETIC-PEPTIDE (ANP) AND ARGININE-VASOPRESSIN (AVP) SECRETION IN PATIENTS WITH ACTIVE RENAL STONE DISEASE (ARSD), Journal of the American Society of Nephrology, 5(3), 1994, pp. 866-866

Authors: KOKOT F
Citation: F. Kokot, DEDICATION TO HEIDLAND,AUGUST, Nephrology, dialysis, transplantation, 9, 1994, pp. 3-3

Authors: KOKOT F NIESZPOREK T WIECEK A MARCINKOWSKI W RUDKA R TREMBECKI J
Citation: F. Kokot et al., INFLUENCE OF LONG-TERM ERYTHROPOIETIN TREATMENT ON INSULIN, GLUCAGON,PANCREATIC-POLYPEPTIDE, AND GASTRIN-SECRETION IN HEMODIALYZED PATIENTS, Nephrology, dialysis, transplantation, 9, 1994, pp. 35-39

Authors: FRANEK E MARCINKOWSKI W KOKOT F WIECEK A NOWICKI M
Citation: E. Franek et al., A SINGLE-DOSE OF CYCLOPHOSPHAMIDE (CPH) DOES INCREASE ERYTHROPOIETIN CONCENTRATION IN PATIENTS WITH HYPERTENSION DUE TO VASCULITIS, Clinical nephrology, 42(2), 1994, pp. 139-140

Authors: KOKOT M KOKOT F FRANEK E WIECEK A NOWICKI M DULAWA J
Citation: M. Kokot et al., EFFECT OF ISOBARIC HYPEROXEMIA ON ERYTHROPOIETIN SECRETION IN HYPERTENSIVE PATIENTS, Hypertension, 24(4), 1994, pp. 486-490

Authors: FRANEK E KOKOT F WIECEK A PAWLOWSKI W MYRTA J SZEWCZYK W BAR A
Citation: E. Franek et al., ERYTHROPOIETIN CONCENTRATION IN CYST FLUID IN PATIENTS WITH SIMPLE RENAL CYSTS, Nephron, 67(4), 1994, pp. 431-435
Risultati: 1-25 | 26-50 | 51-55